ASX - Delayed Quote AUD

Anagenics Limited (AN1.AX)

Compare
0.0080
0.0000
(0.00%)
At close: August 29 at 3:30:16 PM GMT+10
Loading Chart for AN1.AX
  • Previous Close 0.0080
  • Open 0.0080
  • Bid 0.0070 x --
  • Ask 0.0080 x --
  • Day's Range 0.0080 - 0.0080
  • 52 Week Range 0.0060 - 0.0160
  • Volume 93,853
  • Avg. Volume 0
  • Market Cap (intraday) 3.691M
  • Beta (5Y Monthly) -0.21
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0200
  • Earnings Date Feb 28, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Anagenics Limited engages in the health wellness and beauty business. The company develops, manufactures, and markets anti-ageing hair care products under the évolis brand; and skin, hair, and body care products under the Uspa brand name. It also imports and distributes skin care and wellbeing products to spas, clinics, salons, retail stores, and online in Australia, New Zealand, and the Pacific Islands. The company was formerly known as Cellmid Limited and changed its name to Anagenics Limited in December 2021. Anagenics Limited was incorporated in 2004 and is based in Sydney, Australia.

anagenics.com

--

Full Time Employees

June 30

Fiscal Year Ends

Recent News: AN1.AX

View More

Performance Overview: AN1.AX

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .

YTD Return

AN1.AX
0.00%
S&P/ASX 200 [XJO] (^AXJO)
6.02%

1-Year Return

AN1.AX
33.33%
S&P/ASX 200 [XJO] (^AXJO)
1.36%

3-Year Return

AN1.AX
83.52%
S&P/ASX 200 [XJO] (^AXJO)
2.05%

5-Year Return

AN1.AX
96.79%
S&P/ASX 200 [XJO] (^AXJO)
51.31%

Compare To: AN1.AX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: AN1.AX

View More

Valuation Measures

Annual
As of 11/26/2024
  • Market Cap

    3.69M

  • Enterprise Value

    2.84M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.30

  • Price/Book (mrq)

    1.36

  • Enterprise Value/Revenue

    0.26

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -82.78%

  • Return on Assets (ttm)

    -27.30%

  • Return on Equity (ttm)

    -135.49%

  • Revenue (ttm)

    7.26M

  • Net Income Avi to Common (ttm)

    -6.38M

  • Diluted EPS (ttm)

    -0.0200

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    471.13k

  • Total Debt/Equity (mrq)

    27.93%

  • Levered Free Cash Flow (ttm)

    -1.26M

Research Analysis: AN1.AX

View More

Company Insights: AN1.AX

Research Reports: AN1.AX

View More